SOMIAXON (Ceftriaxone 1 gm Injection)
A Powerful Third-Generation Cephalosporin for Broad-Spectrum Antibacterial Coverage
SOMIAXON contains Ceftriaxone 1 gm, a leading third-generation cephalosporin known for its wide antibacterial spectrum, high stability against beta-lactamases, and long-lasting therapeutic action. It is widely trusted for managing severe and life-threatening infections.
Key Features & Benefits
- Exhibits broad-spectrum antibacterial activity against Gram-positive and Gram-negative organisms
- Highly stable in the presence of beta-lactamases (penicillinase & cephalosporinase)
- Excellent penetration into cerebrospinal fluid (CSF), especially in inflamed meninges
- Longest half-life among cephalosporins, allowing convenient dosing
- Effective in preventing post-operative infections (both local and systemic)
- Proven efficacy in serious and hospital-acquired infections
Indications
SOMIAXON is indicated for the treatment of:
- Meningitis
- Surgical wound infections
- Bacterial septicemia
- Nosocomial (hospital-acquired) pneumonia
- Bone and joint infections
- Skin and soft tissue infections
Dosage & Administration
- Each vial contains Ceftriaxone 1 gm
- Administered via Intravenous (IV) or Intramuscular (IM) route
- Dosage and duration should be as prescribed by a healthcare professional
Pharmacological Advantages
- Long duration of action supports once-daily dosing in many cases
- Rapid onset ensures quick control of infection
- Reliable performance in critical care settings
Safety & Tolerability
- Generally well tolerated when used as directed
- Established safety profile in a wide range of infections
- Suitable for both inpatient and outpatient settings
Why Choose SOMIAXON?
- Trusted cephalosporin with proven clinical efficacy
- Handles complex and severe infections with confidence
- Ideal for hospital and emergency use
Packaging
- Available in 1 gm vial (Ceftriaxone Injection)
Tagline
Handles Any Infection Challenge